Live from the NIH registry
Studies recruiting near Cape Coral right now
Top 25 of 246 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
Persistent Corneal Epithelial Defect
Phase 2
Interventional 84 participants sought
Glaukos Investigative Site — Fort Myers, Florida (9.7 mi)
· Sponsor: Glaukos Corporation
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (9.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Fort Myers, Florida (9.7 mi)
· Sponsor: AstraZeneca
The Purpose of This Study is to Evaluate Efficacy and Safety of NT-101 Eye Drops in Patients With Wet Age-Related Macular Degeneration (AMD)
Wet Age Related Macular Degeneration
Phase 2
Interventional 66 participants sought
Advanced Retina Institute — Bonita Springs, Florida (25.0 mi)
· Sponsor: NexThera Co., Ltd.
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Florida Cancer Specialists South / Sarah Cannon Research Institute — Cape Coral, Florida (6.3 mi)
· Sponsor: American Society of Clinical Oncology
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
CIN 2/3, HPV Infection
Phase 2
Interventional 78 participants sought
Florida Gynecologic Oncology — Fort Myers, Florida (9.7 mi)
· Sponsor: Frantz Viral Therapeutics, LLC
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Florida Cancer Specialists - SOUTH - SCRI - PPDS — Fort Myers, Florida (9.7 mi)
· Sponsor: Hoffmann-La Roche
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Innovative Research Institute — Port Charlotte, Florida (23.7 mi)
· Sponsor: Sparrow Pharmaceuticals
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Type 2 Diabetes
Phase 2
Interventional 300 participants sought
Southwest General Healthcare Center — Fort Myers, Florida (9.7 mi)
· Sponsor: Housey Healthcare ULC
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
Southwest Florida Proton Center — Fort Myers, Florida (9.7 mi)
· Sponsor: Proton Collaborative Group
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1165 — Fort Myers, Florida (9.7 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Fort Myers, Florida (9.7 mi)
· Sponsor: Akero Therapeutics, Inc
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Florida Cancer Specialists - South — Fort Myers, Florida (9.7 mi)
· Sponsor: SCRI Development Innovations, LLC
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
Peace River Cardiovascular Center — Port Charlotte, Florida (23.7 mi)
· Sponsor: Novartis Pharmaceuticals
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Colon Adenocarcinoma, Rectal Adenocarcinoma
Phase 3
Interventional 477 participants sought
Florida Cancer Specialists - South ( Site 7002) — Fort Myers, Florida (9.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Regurgitation
N/A
Interventional 1,056 participants sought
HealthPark Medical Center — Fort Myers, Florida (9.7 mi)
· Sponsor: Medtronic Cardiovascular
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Florida Cancer Specialists — Cape Coral, Florida (6.3 mi)
· Sponsor: Pfizer
Quality of End-of-Life Care for Children With Cancer
Childhood Hematopoietic and Lymphatic System Neoplasm, Childhood Malignant Solid Neoplasm
N/A
Observational 2,425 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (9.7 mi)
· Sponsor: Children's Oncology Group
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Obesity, Overweight
Phase 3
Interventional 1,100 participants sought
ACCOMPLISH-2 Research Site — Fort Myers, Florida (9.7 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
Degenerative Disc Disease (DDD)
N/A
Interventional 225 participants sought
Southwest Florida Pain Center — Port Charlotte, Florida (23.7 mi)
· Sponsor: ReGelTec, Inc.
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Low Grade Serous Ovarian Cancer
Phase 3
Interventional 270 participants sought
Florida Cancer Specialists - South — Fort Myers, Florida (9.7 mi)
· Sponsor: Verastem, Inc.
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Florida Cancer Specialists South — Fort Myers, Florida (9.7 mi)
· Sponsor: Janssen Research & Development, LLC
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Covenant Metabolic Specialists, LLC - Fort Myers — Fort Myers, Florida (9.7 mi)
· Sponsor: Boehringer Ingelheim
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 410 participants sought
Local Institution - 1020 — Bonita Springs, Florida (25.0 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 12 — Fort Myers, Florida (9.7 mi)
· Sponsor: Merus B.V.